Fairey AS - Search Results

1

Neoadjuvant chemotherapy with gemcitabine/cisplatin vs. methotrexate/vinblastine/doxorubicin/cisplatin for muscle-invasive urothelial carcinoma of the bladder: a retrospective analysis from the University of Southern California.

Fairey AS, Daneshmand S, Quinn D, Dorff T, Dorin R, Lieskovsky G, Schuckman A, Cai J, Miranda G, Skinner EC. Fairey AS, et al. Urol Oncol. 2013 Nov;31(8):1737-43. doi: 10.1016/j.urolonc.2012.07.005. Epub 2012 Nov 7. Urol Oncol. 2013. PMID: 23141776

2

Clinical analysis of EV-Fingerprint to predict grade group 3 and above prostate cancer and avoid prostate biopsy.

Fairey A, Paproski RJ, Pink D, Sosnowski DL, Vasquez C, Donnelly B, Hyndman E, Aprikian A, Kinnaird A, Beatty PH, Lewis JD. Fairey A, et al. Cancer Med. 2023 Aug;12(15):15797-15808. doi: 10.1002/cam4.6216. Epub 2023 Jun 17. Cancer Med. 2023. PMID: 37329212 Free PMC article.

3

Disparities in prostate cancer screening, diagnoses, management, and outcomes between Indigenous and non-Indigenous men in a universal health care system.

Kiciak A, Clark W, Uhlich M, Letendre A, Littlechild R, Lightning P, Vasquez C, Singh R, Broomfield S, Martin AM, Huang G, Fairey A, Kolinsky M, Wallis CJD, Fung C, Hyndman E, Yip S, Bismar TA, Lewis J, Ghosh S, Kinnaird A. Kiciak A, et al. Cancer. 2023 Sep 15;129(18):2864-2870. doi: 10.1002/cncr.34812. Epub 2023 Jul 10. Cancer. 2023. PMID: 37424308 Free article.

4

Age ≥ 80 years is independently associated with survival outcomes after radical cystectomy: results from the Canadian Bladder Cancer Network Database.

Fairey AS, Kassouf W, Aprikian AG, Chin JL, Izawa JI, Fradet Y, Lacombe L, Rendon RA, Bell D, Cagiannos I, Drachenberg DE, Lattouf JB, Estey EP. Fairey AS, et al. Urol Oncol. 2012 Nov-Dec;30(6):825-32. doi: 10.1016/j.urolonc.2011.07.014. Epub 2011 Sep 1. Urol Oncol. 2012. PMID: 21889368

5

Outcomes after radical prostatectomy for patients with clinical stages T1-T2 prostate cancer with pathologically positive lymph nodes in the prostate-specific antigen era.

Dorin RP, Lieskovsky G, Fairey AS, Cai J, Daneshmand S. Dorin RP, et al. Among authors: fairey as. Urol Oncol. 2013 Nov;31(8):1441-7. doi: 10.1016/j.urolonc.2012.03.006. Epub 2012 Apr 18. Urol Oncol. 2013. PMID: 22516714

6

Robotic intracorporeal orthotopic ileal neobladder: replicating open surgical principles.

Goh AC, Gill IS, Lee DJ, de Castro Abreu AL, Fairey AS, Leslie S, Berger AK, Daneshmand S, Sotelo R, Gill KS, Xie HW, Chu LY, Aron M, Desai MM. Goh AC, et al. Among authors: fairey as. Eur Urol. 2012 Nov;62(5):891-901. doi: 10.1016/j.eururo.2012.07.052. Epub 2012 Aug 17. Eur Urol. 2012. PMID: 22920581

7

Multifocality rather than tumor location is a prognostic factor in upper tract urothelial carcinoma.

Williams AK, Kassouf W, Chin J, Rendon R, Jacobsen N, Fairey A, Kapoor A, Black P, Lacombe L, Tanguay S, So A, Lattouf JB, Bell D, Fradet Y, Saad F, Matsumoto E, Drachenberg D, Cagiannos I, Izawa JI. Williams AK, et al. Urol Oncol. 2013 Oct;31(7):1161-5. doi: 10.1016/j.urolonc.2011.12.004. Epub 2013 Feb 13. Urol Oncol. 2013. PMID: 23415596

8

Adjuvant chemotherapy for upper-tract urothelial carcinoma treated with nephroureterectomy: assessment of adequate renal function and influence on outcome.

Yafi FA, Tanguay S, Rendon R, Jacobsen N, Fairey A, Izawa J, Kapoor A, Black P, Lacombe L, Chin J, So A, Lattouf JB, Bell D, Fradet Y, Saad F, Matsumoto E, Drachenberg D, Cagiannos I, Kassouf W. Yafi FA, et al. Urol Oncol. 2014 Jan;32(1):31.e17-24. doi: 10.1016/j.urolonc.2012.11.014. Epub 2013 Feb 18. Urol Oncol. 2014. PMID: 23428535

9

Impact of micropapillary urothelial carcinoma variant histology on survival after radical cystectomy.

Fairey AS, Daneshmand S, Wang L, Schuckman A, Lieskovsky G, Djaladat H, Cai J, Miranda G, Skinner EC. Fairey AS, et al. Urol Oncol. 2014 Feb;32(2):110-6. doi: 10.1016/j.urolonc.2012.04.020. Epub 2013 Mar 14. Urol Oncol. 2014. PMID: 23499168

10

Long-term cancer control after radical prostatectomy and bilateral pelvic lymph node dissection for pT3bN0M0 prostate cancer in the prostate-specific antigen era.

Fairey AS, Daneshmand S, Skinner EC, Schuckman A, Cai J, Lieskovsky G. Fairey AS, et al. Urol Oncol. 2014 Feb;32(2):85-91. doi: 10.1016/j.urolonc.2013.03.005. Epub 2013 Oct 30. Urol Oncol. 2014. PMID: 24183191

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

106 results

Search Page

Filters